Cargando…

Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism

The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Alok, Landyn, Valentina, Wagner, Joann, Burgwinkle, Pamela, Huang, Wei, Gore, Joel, Spencer, Frederick A., Goldberg, Robert, McManus, David D., Darling, Chad, Boudreaux, Edwin, Barton, Bruce, Mazor, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678649/
https://www.ncbi.nlm.nih.gov/pubmed/30702452
http://dx.doi.org/10.1097/PTS.0000000000000571
_version_ 1783612200887255040
author Kapoor, Alok
Landyn, Valentina
Wagner, Joann
Burgwinkle, Pamela
Huang, Wei
Gore, Joel
Spencer, Frederick A.
Goldberg, Robert
McManus, David D.
Darling, Chad
Boudreaux, Edwin
Barton, Bruce
Mazor, Kathleen M.
author_facet Kapoor, Alok
Landyn, Valentina
Wagner, Joann
Burgwinkle, Pamela
Huang, Wei
Gore, Joel
Spencer, Frederick A.
Goldberg, Robert
McManus, David D.
Darling, Chad
Boudreaux, Edwin
Barton, Bruce
Mazor, Kathleen M.
author_sort Kapoor, Alok
collection PubMed
description The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. METHODS: We randomized patients to the intervention or control. During the home visit, a clinical pharmacist assessed medication management proficiency, asked open-ended questions to discuss knowledge gaps, and distributed illustrated medication instructions. Subsequent consultation with anticoagulation expert further filled knowledge gaps. At 30 days, we assessed satisfaction with the intervention and also measured the quality of care transition, knowledge of anticoagulation and venous thromboembolism, and anticoagulant beliefs (level of agreement that anticoagulant is beneficial, is worrisome, and is confusing/difficult to take). RESULTS: The mean ± SD time required to conduct home visits was 52.4 ± 20.5 minutes and most patients agreed that the intervention was helpful. In general, patients reported a high-quality care transition including having been advised of safety issues related to medications. Despite that, the mean percentage of knowledge items answered correctly among patients was low (51.5 versus 50.7 for intervention and controls, respectively). We did not find any significant difference between intervention and control patients for care transition quality, knowledge, or anticoagulant beliefs. CONCLUSIONS: We executed a multicomponent intervention that was feasible and rated highly. Nevertheless, the intervention did not improve care transition quality, knowledge, or beliefs. Future research should examine whether alternate strategies potentially including some but not all components of our intervention would be more impactful.
format Online
Article
Text
id pubmed-7678649
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-76786492020-11-23 Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism Kapoor, Alok Landyn, Valentina Wagner, Joann Burgwinkle, Pamela Huang, Wei Gore, Joel Spencer, Frederick A. Goldberg, Robert McManus, David D. Darling, Chad Boudreaux, Edwin Barton, Bruce Mazor, Kathleen M. J Patient Saf Original Articles The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. METHODS: We randomized patients to the intervention or control. During the home visit, a clinical pharmacist assessed medication management proficiency, asked open-ended questions to discuss knowledge gaps, and distributed illustrated medication instructions. Subsequent consultation with anticoagulation expert further filled knowledge gaps. At 30 days, we assessed satisfaction with the intervention and also measured the quality of care transition, knowledge of anticoagulation and venous thromboembolism, and anticoagulant beliefs (level of agreement that anticoagulant is beneficial, is worrisome, and is confusing/difficult to take). RESULTS: The mean ± SD time required to conduct home visits was 52.4 ± 20.5 minutes and most patients agreed that the intervention was helpful. In general, patients reported a high-quality care transition including having been advised of safety issues related to medications. Despite that, the mean percentage of knowledge items answered correctly among patients was low (51.5 versus 50.7 for intervention and controls, respectively). We did not find any significant difference between intervention and control patients for care transition quality, knowledge, or anticoagulant beliefs. CONCLUSIONS: We executed a multicomponent intervention that was feasible and rated highly. Nevertheless, the intervention did not improve care transition quality, knowledge, or beliefs. Future research should examine whether alternate strategies potentially including some but not all components of our intervention would be more impactful. Lippincott Williams & Wilkins 2020-12 2019-01-29 /pmc/articles/PMC7678649/ /pubmed/30702452 http://dx.doi.org/10.1097/PTS.0000000000000571 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Articles
Kapoor, Alok
Landyn, Valentina
Wagner, Joann
Burgwinkle, Pamela
Huang, Wei
Gore, Joel
Spencer, Frederick A.
Goldberg, Robert
McManus, David D.
Darling, Chad
Boudreaux, Edwin
Barton, Bruce
Mazor, Kathleen M.
Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
title Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
title_full Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
title_fullStr Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
title_full_unstemmed Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
title_short Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
title_sort supplying pharmacist home visit and anticoagulation professional consultation during transition of care for patients with venous thromboembolism
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678649/
https://www.ncbi.nlm.nih.gov/pubmed/30702452
http://dx.doi.org/10.1097/PTS.0000000000000571
work_keys_str_mv AT kapooralok supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT landynvalentina supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT wagnerjoann supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT burgwinklepamela supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT huangwei supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT gorejoel supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT spencerfredericka supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT goldbergrobert supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT mcmanusdavidd supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT darlingchad supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT boudreauxedwin supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT bartonbruce supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism
AT mazorkathleenm supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism